Jan Petracek, MD, MSc, DIC
Chief Executive Officer
Jan is an expert in pharmacovigilance and risk management. He is the former Head of Risk Management Section at the European Medicines Agency, and the former Head of Pharmacovigilance, Strategy and Development at the State Institute for Drug Control in the Czech Republic. He has unique education in Quality and Safety in Healthcare (MSc) from the Imperial College London, and trained as a physician at Charles University in Prague (MD). He has written and/or contributed to many national and international guidelines, including ICH E2F, EMA Guideline on Safety and Efficacy Follow-up - Risk Management of Advanced Therapies, and parts of Volume 9A. In April 2017, Jan stepped into the role of Chief Executive Officer of PrimeVigilance. In December 2017, Jan has joined the Board of Ergomed PLC and has been appointed Chief Operating Officer of Ergomed PLC.